MedPath

Comorbidity and Pulmonary Rehabilitation in COPD

Not Applicable
Completed
Conditions
COPD
Interventions
Other: Exercise
Registration Number
NCT03319108
Lead Sponsor
Izmir Katip Celebi University
Brief Summary

Our aim in this study is to determine the distribution of comorbidity in patients with COPD participating in the pulmonary rehabilitation program and to examine the effect of severity of comorbidy on pulmonary rehabilitation outcomes.

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) is associated not only with respiratory system effects but also with systemic outcomes leading to numerous chronic comorbidities, and it is well known that patients benefit from pulmonary rehabilitation programs. However, the effect of presence of comorbidity on the outcome of pulmonary rehabilitation in patients with COPD is not clear. Therefore, our aim in this study is to determine the distribution of comorbidity in patients with COPD participating in the pulmonary rehabilitation program and to examine the effect of severity of comorbidy on pulmonary rehabilitation outcomes We included a total of 173 patients referred to the Izmir Suat Seren Chest Diseases and Surgery Training and Research Hospital Pulmonary Rehabilitation Unit. Comorbidities were recorded based on self reports. Charlson Comorbid Indexes (CCI) were calculated. Patients who defined at least one comorbidity were divided into two groups according to CCI; 1-3 as Group 1 and 4 and above as Group 2. Six minute walk test, mMRC dyspnea scale, SGRQ Respiratory Disease Questionnaire, respiratory function tests and arterial blood gases performed for assessment of patients before and after 16 sessions of pulmonary rehabilitation program.

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
173
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low Comorbidity Index ScoreExerciseCCI; 1-3 as Group 1
High Comorbidity Index ScoreExerciseCCI; 4 and above as Group 2
Primary Outcome Measures
NameTimeMethod
Exercise Capacity6 minute

Six minute walk test

Secondary Outcome Measures
NameTimeMethod
Respiratory Functions30 minutes

Pulmonary Function Tests

Disease Specific Quality of Life20 minutes

St George Respiratory Questionnaire

Health Related Quality of Life20 minutes

SF-36

Dyspnea5 minutes

MMRC dyspnea scale

© Copyright 2025. All Rights Reserved by MedPath